Select Medical Holdings Co. (NYSE:SEM) insider Scott A. Romberger sold 5,000 shares of the stock in a transaction dated Monday, June 11th. The stock was sold at an average price of $18.63, for a total value of $93,150.00. Following the completion of the sale, the insider now owns 158,485 shares of the company’s stock, valued at $2,952,575.55. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link.
Shares of NYSE SEM opened at $18.40 on Thursday. Select Medical Holdings Co. has a 52 week low of $13.90 and a 52 week high of $19.77. The company has a quick ratio of 1.66, a current ratio of 1.66 and a debt-to-equity ratio of 3.60. The company has a market cap of $2.51 billion, a P/E ratio of 18.97, a P/E/G ratio of 1.27 and a beta of 1.31.
Select Medical (NYSE:SEM) last issued its quarterly earnings results on Thursday, May 3rd. The health services provider reported $0.29 EPS for the quarter, beating the consensus estimate of $0.26 by $0.03. Select Medical had a return on equity of 15.19% and a net margin of 4.23%. The firm had revenue of $1.25 billion during the quarter, compared to analysts’ expectations of $1.23 billion. During the same period in the prior year, the firm posted $0.21 earnings per share. The business’s quarterly revenue was up 14.7% compared to the same quarter last year. equities research analysts anticipate that Select Medical Holdings Co. will post 1.05 EPS for the current year.
A number of research analysts recently issued reports on the company. TheStreet upgraded Select Medical from a “c+” rating to a “b-” rating in a report on Thursday, March 1st. JMP Securities upgraded Select Medical from an “underperform” rating to a “market perform” rating and set a $12.00 price objective for the company in a report on Tuesday, February 27th. Zacks Investment Research downgraded Select Medical from a “buy” rating to a “hold” rating in a report on Wednesday, March 14th. ValuEngine downgraded Select Medical from a “strong-buy” rating to a “buy” rating in a report on Wednesday, March 7th. Finally, Robert W. Baird reiterated a “buy” rating and set a $26.00 price objective on shares of Select Medical in a report on Friday, February 23rd. Four research analysts have rated the stock with a hold rating and six have assigned a buy rating to the stock. The stock currently has a consensus rating of “Buy” and a consensus target price of $20.63.
About Select Medical
Select Medical Holdings Corporation, through its subsidiary, Select Medical Corporation, operates acute care hospitals (LTCHs), inpatient rehabilitation facilities (IRFs), outpatient rehabilitation clinics, and occupational medicine centers in the United States. The company operates through four segments: Long Term Acute Care, Inpatient Rehabilitation, Outpatient Rehabilitation, and Concentra.
Receive News & Ratings for Select Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Select Medical and related companies with MarketBeat.com's FREE daily email newsletter.